NCT03298815View on ClinicalTrials.gov

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

December 16, 2022

Study Completion Date

February 24, 2023

Conditions
Ocular Graft Versus Host Disease
Interventions
BIOLOGICAL

Amniotic Fluid Eye Drops (AFED)

One drop (0.25 mL) in one eye twice daily for up to 3 months

OTHER

Saline Solution

One drop (0.25 mL) in the other eye twice daily for up to 3 months

Trial Locations (1)

84112

University of Utah Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT03298815 - Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED) | Biotech Hunter | Biotech Hunter